Anzeige
Mehr »
Donnerstag, 04.09.2025 - Börsentäglich über 12.000 News
Set to Action: Q-Gold vor drastischer Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
255 Leser
Artikel bewerten:
(1)

HealthSnap Receives Graphical User Interface Patent for Best in Class Remote Patient Monitoring Platform Billing Automation Feature

MIAMI, FL / ACCESSWIRE / April 27, 2022 / HealthSnap, a Miami-based full-service Remote Patient Monitoring (RPM) platform for virtual chronic disease management, announced today that it has been issued a Graphical User Interface (GUI) patent by the United States Patent and Trademark Office (USPTO) for its innovative and visual RPM billing technology. The patented tool is available within HealthSnap's provider portal and simplifies the Center for Medicare and Medicaid Services (CMS) billing and compliance requirements for RPM CPT codes.

"Ensuring healthcare providers recognize optimal financial outcomes with HealthSnap's RPM program is imperative to long-term sustainability. We are proud to announce this major milestone in HealthSnap's product development and look forward to continuing to support our customers in a rapidly changing reimbursement landscape," said Chase Preston, Co-Founder, and Chief Product Officer.

HealthSnap , Wednesday, April 27, 2022, Press release picture

HealthSnap's patented tool helps to automate tasks required to successfully document and receive reimbursement for RPM, such as patient enrollment workflows, clinical documentation automation, and visual CPT Code eligibility reporting, all of which enable providers to spend less time on compliance and clerical work and more time on providing patient care.

The company's patent, received during Q1-22, is for HealthSnap's visual billing automation feature, or "Eligibility Report," which displays a breakdown of each patient and the CPT codes eligible for RPM billing. This patent extends not only to RPM but to other codes as well including Chronic Care Management (CCM) billing codes. This newly patented tool was specifically designed to make it easy for healthcare providers to stay compliant with CMS guidelines to ensure seamless billing.

"This milestone marks HealthSnap's commitment to being a leader in virtual care management, and further sets the company apart as a best in class digital health platform serving the healthcare provider market. HealthSnap aims to make RPM and CCM simple, profitable, and scalable so that healthcare providers are able to provide virtual chronic disease management to patients, with long-term sustainability in mind," said Samson Magid, Co-Founder, and CEO.

HealthSnap provides virtual care management solutions that help healthcare providers manage chronic conditions such as hypertension, diabetes, and heart failure virtually by combining the power of an integrated care management platform that supports RPM and Chronic Care Management (CCM) programs, pre-configured and cellular-enabled health devices, and patient care management services all in one end-to-end solution.

By providing full-service care management tools and services, HealthSnap provides a care delivery paradigm that is proactive, ongoing, and delivered in the home - where chronic conditions take place. As a result, HealthSnap has been able to demonstrate improved patient outcomes, decreased utilization, and marked improvements in the overall patient experience. To date, HealthSnap has contracted with over 100 physician groups, including top 10 health systems, Federally Qualified Health Centers (FQHCs), and Independent Physician Groups (IPAs).

About HealthSnap

HealthSnap is an integrated Virtual Care Platform that helps healthcare organizations improve patient outcomes, reduce utilization, and diversify revenue streams. From chronic disease-agnostic Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) to AI-guided care coordination, virtual care delivery, automated RPM billing, population analytics - and so much more, HealthSnap is the simplest way to manage chronic conditions remotely.

Visit www.healthsnap.io or follow us on LinkedIn for more information.

Contact:
Sunny Ghia
sunny@healthsnap.io
610-442-4463

SOURCE: HealthSnap



View source version on accesswire.com:
https://www.accesswire.com/698791/HealthSnap-Receives-Graphical-User-Interface-GUI-Patent-for-Best-in-Class-Remote-Patient-Monitoring-Platform-Billing-Automation-Feature

© 2022 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.